Skeletal Muscle UCHL1 Negatively Regulates Muscle Development and Recovery after Muscle Injury.

Area of Science:

• Biochemistry
• Molecular Biology
• Muscle Physiology

Background:

• Ubiquitin C-terminal hydrolase L1 (UCHL1) is a deubiquitinating enzyme.
• UCHL1 is expressed in skeletal muscle and influences myoblast differentiation and metabolism.
• The role of UCHL1 in myogenesis and muscle regeneration requires further investigation.

Purpose of the Study:

• To investigate the role of UCHL1 in myogenesis.
• To determine the effect of UCHL1 on muscle regeneration following ischemia-reperfusion (IR) injury.
• To explore UCHL1 as a potential therapeutic target for muscle injury.

Main Methods:

• C2C12 myoblast cell culture with UCHL1 knockdown.
• Skeletal muscle-specific knockout (smKO) mouse model.
• Ischemia-reperfusion (IR) injury model in hindlimb muscle.
• Analysis of myogenic factors (MyoD, myogenin), muscle fiber size, inflammation, and functional recovery.
• Assessment of Akt and Pink1/Parkin signaling pathways.

Main Results:

• UCHL1 knockdown in C2C12 cells upregulated MyoD and myogenin, promoting myotube formation.
• Skeletal muscle-specific knockout of UCHL1 increased muscle fiber size in young mice.
• UCHL1 was upregulated in IR-injured muscle.
• UCHL1 smKO ameliorated IR-induced tissue damage, inflammation, and improved functional recovery.
• UCHL1 smKO enhanced Akt and Pink1/Parkin activities in IR injury models.

Conclusions:

• Skeletal muscle UCHL1 acts as a negative regulator in muscle development and regeneration.
• Targeting UCHL1 may improve muscle regeneration and functional recovery after IR injury.
• UCHL1 modulation presents a potential therapeutic strategy for muscle-related disorders.